Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener Medizinische Wochenschrift
Erschienen in:

01.11.2012 | main topic

Diagnosis of anaemia: old things rearranged

verfasst von: Prim. Univ.-Prof. Dr. Gabriele Halwachs-Baumann, MSc, MBA

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 21-22/2012

Einloggen, um Zugang zu erhalten

Summary

Anaemia is one of the most leading causes of morbidity and mortality, as declared by the World Health Organisation. This syndrome is characterised by low haemoglobin levels and nonspecific clinical symptoms such as weakness, fatigue and dyspnoea. The symptoms are unspecific as the underlying causes are heterogeneous. Thus, good knowledge of the useful bisickomarkers and their correct assignment is needed to allow rapid and targeted diagnosis.
Vorheriger Artikel Biomarkers of bone turnover in diagnosis and therapy of osteoporosis
Nächster Artikel Biomarkers in acute coronary artery disease
Fußnoten
1
Serum transferrin (TF) (g/l) = 0.007 ´ Total iron-binding capacity (TIBC) (mg/l)
TIBC (mg/dl) = TF (mg/dl) ´ 1.41
TIBC (mmol/l) = TF (g/l) ´ 25.2
Transferrin saturation (TSAT) (%) = serum iron (mg/dl)/TF (mg/dl) ´ 70.9
TSAT (%) = serum iron (mmol/l)/TF (mg/dl) ´ 398
 
Literatur
1.
World Health Organization. Nutritional anaemias: report of a WHO scientific group. WHO Tech Rep Ser. 1968;405:1–40.
2.
Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood haemoglobin concentration? Blood. 2006;107:1747–50.PubMedCrossRef
3.
Rushton DH, Dover R, Sainsbury AW, et al. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ. 2001;322:1355–7.PubMedCrossRef
4.
Waalen J, Felitti V, Beutler E. Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ. 2002;325:137.
5.
Milman N, Pedersen AN, Ovesen L, et al. Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age? Aging Clin Exp Res. 2008;20:8–14.PubMed
6.
Cheng CK, Chan J, Cembrowski GS, et al. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex and race. Lab Hematol. 2004;10:42–53.PubMedCrossRef
7.
Navaneethan SD, Bonifati C, Schena FP, et al. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006;19:640–7.PubMed
8.
Dicato M. Venous thromboembolic events and erythropoiesis-stimulating agents: an update. Oncologist. 2008;13:11–5.PubMedCrossRef
9.
Pirker R. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. Expert Opin Drug Saf. 2009;8:515–22.PubMedCrossRef
10.
Al Diab Al. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther. 2010;3:191–5.PubMed
11.
Mimoz O, Frasca D, Médard A, et al. Reliability of the HemoCue® hemoglobinometer in critically ill patients: a prospective observational study. Minerva Anestesiol. 2011;77:979–85.PubMed
12.
Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martin M. Classification of anemia for gastroenterologists. World J Gastroenterol. 2009;15:4627–37.PubMedCrossRef
13.
Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4:537–45.PubMedCrossRef
14.
15.
Kohne E, Kleihauer E. Hämoglobinopathien—eine Langzeitstudie über vier Jahrzehnte. Dtsch Ärztebl Int. 2010;107:65–71.PubMed
16.
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
17.
Koulaouzidis A, Said E, Cottier R, et al. Soluble Transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009;18:345–52.PubMed
18.
Beris P, Munoz M, Garcia-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008;100:599–604.PubMedCrossRef
19.
Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr. 2001;131:616S–35S.PubMed
20.
Gasche C, Lomer MCE, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190–7.PubMedCrossRef
21.
Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol. 2002;117:802–8.PubMedCrossRef
22.
Heimpel H, Riedel M, Wennauer R, et al. Die Plasmaeisenbestimmung – nützlich, unnötig oder irreführend? Med Klin. 2003;98:104–7.CrossRef
23.
Adams PC, Reboussin DM, Press RD, et al. Biological variability of transferrin saturation and unsaturated iron binding capacity. Am J Med. 2007;120:999.e1–7.
24.
Kasvosve I, Delanghe J. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clim Chem Lab Med. 2002;40:1014–8.
25.
Coyne D. Iron indices: what do they really mean? Kidney Int. 2006;69:S4–8.CrossRef
26.
Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1:S4–8.PubMedCrossRef
27.
28.
Formanowicz D, Formanowicz P. Transferrin changes in haemodialysed patients. Int Urol Nephrol. 2012;44:907–19.PubMedCrossRef
29.
Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response—lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45:18–32.PubMedCrossRef
30.
Van Vranken M. Evaluation of microcytosis. Am Fam Physician. 2010;82:1117–22.PubMed
31.
Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta. 2010;1800:783–92.PubMedCrossRef
32.
Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790:589–99.PubMedCrossRef
33.
Cook JD, Lipschitz DA, Miles LEM, et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27:681–7.PubMed
34.
Addison GM, Jacobs A, Walwalters GO, et al. Ferritin in serum. Lancet. 1973;20:154–5.CrossRef
35.
Jacobs A, Worwood M. Ferritin in serum. Clinical and biochemical implications. N Engl J Med. 1975;292:951–6.PubMedCrossRef
36.
Jacobs A, Miller F, Worwood M, et al. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4:206–8.PubMedCrossRef
37.
Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290:1213–6.PubMedCrossRef
38.
Munoz M, Villar I, Garcia-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15:4617–26.PubMedCrossRef
39.
Hallberg L, Bengtsson C, Lapidus L, et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85:787–98.PubMedCrossRef
40.
Stancu S, Stanciu A, Zugravu A, et al. Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2010;55:639–47.PubMedCrossRef
41.
Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73:1–9.PubMedCrossRef
42.
Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent PKC-z/NFkB-regulated signalling in rat hepatic stellate cells. Hepatology. 2009;49:887–900.PubMedCrossRef
43.
Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.PubMedCrossRef
44.
Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116:4754–61.PubMedCrossRef
45.
Ong KH, Tan HL, Lai HC, et al. Accuracy of various parameters in the prediction of iron deficiency in an acute care hospital. Ann Acad Med Singapore. 2005;34:437–40.PubMed
46.
Koulaouzidis A, Cottier R, Bhat S, et al. A ferritin level > 50 mg/L is frequently consistent with iron deficiency. Eur J Intern Med. 2009;20:168–70.PubMedCrossRef
47.
Feelders RA, Kuiper-Kramer EPA, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med. 1999;37:1–10.PubMedCrossRef
48.
Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2011;47:213–28.CrossRef
49.
Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2011;64:281–6.PubMedCrossRef
50.
Ohnishi K, Torimoto Y, Ikuta K, et al. Detection of soluble HFE associated with soluble transferrin receptor in human serum. Int J Mol Med. 2011;27:435–9.PubMed
51.
52.
Thorpe SJ. The development and role of international biological reference materials in the diagnosis of anaemia. Biologicals. 2010;38:449–58.PubMedCrossRef
53.
Thorpe SJ, Heath A, Sharp G, et al. A WHO reference reagent for the serum transferrin receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation. Clin Chem Lab Med. 2010;48:815–20.PubMedCrossRef
54.
Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066–76.PubMed
55.
Phiri KS, Calis JCJ, Siyasiya A, et al. New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area. J Clin Pathol. 2009;62:1103–6.PubMedCrossRef
56.
Yang Z, Dewey KG, Lönnerdal B, et al. Comparison of plasma ferritin concentration with the ratio of plasma transferrin receptor to ferritin in estimating body iron stores: results of 4 intervention trials. Am J Clin Nutr. 2008;87:1892–8.PubMed
57.
Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicentre evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.PubMedCrossRef
58.
Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162:445–9.PubMedCrossRef
59.
Genc S, Erten N, Karan MA, et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients. Tohoku J Exp Med. 2004;202:135–42.PubMedCrossRef
60.
Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol. 2011;64:287–96.PubMedCrossRef
61.
Leers MPG, Keuren JFW, Oosterhuis WP. The value of the Thomas-plot in the diagnostic work up of anemic patients referred by general practitioners. Int J Lab Hematol. 2010;32:572–81.PubMedCrossRef
62.
Thomas C, Kirschbaum A, Boehm D, et al. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol. 2006;23:23–36.PubMedCrossRef
63.
Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005;11:14–23.PubMedCrossRef
64.
Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49:1573–8.PubMedCrossRef
65.
Steinmetz HT, Tsamaloukas A, Schmitz S, et al. A new concept fort the differential diagnosis and therapy of anaemia in cancer patients. Support Care Cancer. 2010;19:261–9.PubMedCrossRef
66.
Katodritou E, Speletas M, Zervas K, et al. Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma. Lab Hematol. 2006;12:47–54.PubMedCrossRef
67.
68.
Thomas C, Kobold U, Thomas L. Serum hepcidin-25 in comparison to biochemical markers and haematological indices for the differentiation of iron-restricted erythropoiesis. Clin Chem Lab Med. 2011;49:207–13.PubMedCrossRef
69.
Ganz T. Hepcidin in its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006;507:29–35.CrossRef
70.
71.
Pasricha SR, McQuilten Z, Westerman M, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96:1099–105.PubMedCrossRef
72.
Thomas C, Kobold U, Balan S, et al. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hem. 2011;33:187–93.CrossRef
73.
Lee P, Gelbart T, Waalen J, et al. The anemia of aging is not associated with increased plasma hepcidin levels. Blood Cells Mol Dis. 2008;41:252–4.PubMedCrossRef
74.
Uehata T, Tomosugi N, Shoji T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. Nephrol Dial Transplant. 2012;27:1076–83.PubMedCrossRef
75.
Guidi GC, Lechi Santonastaso CL. Advancements in anemias related to chronic conditions. Clin Chem Lab Med. 2010;48:1217–26.PubMedCrossRef
76.
Macdougall IC, Malyszko J, Hider RC, et al. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1681–9.PubMedCrossRef
77.
Schwarz P, Strnad P, von Figura G, et al. A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol. 2011;46:648–56.PubMedCrossRef
78.
Koliaraki V, Marinou M, Vassilakopoulos TP, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4:e4581.
79.
Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–7.PubMedCrossRef
80.
Rumjon A, Sarafidis P, Brincat S, et al. Serum hemojuvelin and hepcidin levels in chronic kidney disease. Am J Mephrol. 2012;35:295–304.CrossRef
81.
Malyszko J. Hemojuvelin: the hepcidin story continues. Kidney Blood Press Res. 2009;32:71–6.PubMedCrossRef
82.
Malyszko J, Malyszko JS, Levin-Iaina N. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients? Int Urol Nephrol. (in press).
83.
Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320:1088–92.PubMedCrossRef
84.
Cau M, Melis MA, Congiu R, et al. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin. Expert Rev Hematol. 2010;3:205–16.PubMedCrossRef
85.
Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anaemia in the elderly: the “Health and Anaemia” population-based study. Haematologica. 2010;95:1849–56.PubMedCrossRef
86.
Bassett ML, Goulston KJ. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction. Aust N Z J Med. 1980;10:1–4.PubMedCrossRef
87.
Macrae FA, St John DJ, Caligiore P, et al. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMed
88.
Delco F, Sonnenberg A. Limitations of the faecal occult blood test in screening for colorectal cancer. Ital J Gastroenterol Hepatol. 1999;31:119–26.PubMed
89.
Chrostek L, Cylwik B, Grszewska E, et al. The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values? Alcohol. 2012;46:69–73.PubMedCrossRef
90.
Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70.PubMedCrossRef
91.
Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician. 2004;69:2599–606.PubMed
92.
Müller A, Zimmermann R, Krause SW. Hemolytic anemias in adults. Dtsch Med Wochenschr. 2011;136:2308–12.PubMedCrossRef
93.
Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42:1589–600.PubMed
94.
Gupta S, Ahern K, Nakhl F, et al. Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol. 2011;2011:389854.PubMed
95.
96.
Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disease. Am J Clin Pathol. 2004;121:S97–104.PubMed
97.
Itzecka J. The biological role of haptoglobin and behaviour of this protein in different diseases, with special attention paid to brain stroke. Ann Univ Mariae Curie Sklodowska Med. 1996;51:115–21.
98.
Kasvosve I, Speeckaert MM, Speeckaert R, et al. Haptoglobin polymorphism and infection. Adv Clin Chem. 2010;50:23–46.PubMedCrossRef
99.
Staals J, Henskens LHG, Delanghe JR, et al. Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurevasc Res. 2010;7:1–5.CrossRef
100.
Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79:203–8.PubMed
101.
Savage DG, Ogundipe A, Allen RH, et al. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319:343–52.PubMedCrossRef
102.
Malcovati L, Della Porta MG, Strupp C, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based prognostic scoring System (WPSS). Haematologica. 2011;96:1433–40.PubMedCrossRef
103.
Izaks GJ, Westendorp RGJ, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714–7.PubMedCrossRef
104.
Lechner K, Födinger M, Grisold W, et al. Vitamin B12 Mangel: Neue Daten zu einem alten Thema. Wien Klein Wochenschr. 2005;117:579–91.CrossRef
105.
Fragasso A, Mannarella C, Ciancio A, et al. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anaemic patients. Eur J Intern Med. 2010;21:97–100.PubMedCrossRef
106.
Drammeh BS, Schleicher RL, Pfeiffer CM, et al. Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem. 2008;54:1883–91.PubMedCrossRef
107.
Hustad S, Eussen S, Midttun Ø, et al. Kinetic modelling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem. 2012;58:402–10.PubMedCrossRef
108.
Varela-Moreiras G, Murphy MM, Scott JM. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009;67:S69–72.PubMedCrossRef
109.
Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs Vitamin B(12) and folate. Clin Chem. 2000;46:1277–83.PubMed
110.
Carmel R, Green R, Rosenblatt DS, et al. Update on cobalamin, folate, and homocystein. Hematology Am Soc Hematol Educ Program. 2003:62–81.
111.
Lindenbaum J. Status of laboratory testing in the diagnosis of megaloblastic anemia. Blood. 1983;61:624–7.PubMed
112.
113.
Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15:5121–8.PubMedCrossRef
114.
Presotto F, Sabini B, Cecchetto A, et al. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter. 2003;8:578–84.PubMedCrossRef
Metadaten
Titel
Diagnosis of anaemia: old things rearranged
verfasst von
Prim. Univ.-Prof. Dr. Gabriele Halwachs-Baumann, MSc, MBA
Publikationsdatum
01.11.2012
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 21-22/2012
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0149-1

Weitere Artikel der Ausgabe 21-22/2012

Biomarkers of bone turnover in diagnosis and therapy of osteoporosis

  • main topic

Biomarkers in acute coronary artery disease

  • main topic

Usage and limitations of liquid chromatography-tandem mass spectrometry (LC–MS/MS) in clinical routine laboratories

  • main topic

Labordiagnostik zur Früherkennung und Verlaufskontrolle von systemischen Autoimmunerkrankungen des rheumatischen Formenkreises in der allgemeinmedizinischen Praxis

  • themenschwerpunkt

Biomarkers

  • editorial